Phosphodiesterases in vascular endothelial cells.
Kishi
Y
Y
Third Department of Medicine, Tokyo Medical and Dental University, Japan.
Ashikaga
T
T
Numano
F
F
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000302:isolation & purification; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / Q000494:pharmacology; D000818:Animals; D002417:Cattle; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000032:analysis / Q000378:metabolism; D006152:Cyclic GMP / Q000032:analysis; D004730:Endothelium, Vascular / Q000166:cytology / Q000201:enzymology*; D007700:Kinetics; D020105:Milrinone; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000201:enzymology; D011728:Pyridones / Q000494:pharmacology
D011728:Pyridones; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; D000242:Cyclic AMP; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases; D006152:Cyclic GMP; D020105:Milrinone; D015056:1-Methyl-3-isobutylxanthine